These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32152018)

  • 1. Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial.
    Lum ZK; Khoo ZR; Toh WYS; Kamaldeen SAK; Shakoor A; Tsou KYK; Chew DEK; Dalan R; Kwek SC; Othman N; Lian JX; Bte Sunari RN; Lee JY
    Ann Fam Med; 2020 Mar; 18(2):139-147. PubMed ID: 32152018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study.
    Hassanein M; Shaltout I; Malek R; Assaad Khalil S; Ballout H; Annabi F; Shereen M
    Curr Diabetes Rev; 2024; 20(5):e110823219694. PubMed ID: 37581325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Collaborative Algorithm for the Management of Type 2 Diabetes during Ramadan: An Anchor on Empowerment.
    Lum ZK; See Toh WY; Lim SM; Rusli KDB; Abdul Shakoor SAKK; Tsou KYK; Chew DEK; Dalan R; Kwek SC; Othman N; Lian JX; Lee JY
    Diabetes Technol Ther; 2018 Oct; 20(10):698-703. PubMed ID: 30188180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
    Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
    J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus.
    Sahin SB; Ayaz T; Ozyurt N; Ilkkilic K; Kirvar A; Sezgin H
    Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):531-4. PubMed ID: 23934679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
    Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
    Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis.
    Tahapary DL; Astrella C; Kristanti M; Harbuwono DS; Soewondo P
    Diabetes Metab Syndr; 2020; 14(5):1559-1570. PubMed ID: 32947756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
    Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022.
    Hassanein M; Binte Zainudin S; Shaikh S; Shaltout I; Malek R; Buyukbese MA; Alfadhli EM; Shaikh K; Hussein Z; Eliana F; Hafidh K; El Toony LF; Fariduddin M; Alabbood M; Batais MA; Akter N; Rosandi R; Odhaib SA; Al Amoudi R; Ahmedani MY
    Curr Med Res Opin; 2024 Sep; 40(9):1515-1523. PubMed ID: 39076065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.
    Aziz KM
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitude and safety of patients with diabetes observing the Ramadan fast.
    Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
    Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan.
    Al-Agha AE; Kafi SE; Zain Aldeen AM; Khadwardi RH
    Saudi Med J; 2017 Apr; 38(4):366-371. PubMed ID: 28397942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of structured diabetes education on glycemic control during Ramadan fasting in diabetic patients in Beni Suef, Egypt.
    Nassar M; Ahmed TM; AbdAllah NH; El Sayed El Hadidy K; Sheir RE
    Diabetes Metab Syndr; 2021; 15(5):102249. PubMed ID: 34418633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
    Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
    Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic parameters in type 2 diabetic patients with varying degrees of glycemic control during Ramadan: An observational study.
    Siaw MY; Chew DE; Toh MP; Seah DE; Chua R; Tan J; Lee EY; Chan SY; Lee JY
    J Diabetes Investig; 2016 Jan; 7(1):70-5. PubMed ID: 26816603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.
    Uddin MF; Khan MA; Selim S; Sultana N; Sayem MA; Iftekhar MM; Habib MB; Akter N; Khan S
    J Comp Eff Res; 2024 Feb; 13(2):e230132. PubMed ID: 38294337
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.
    Hassanein M; Abdallah K; Schweizer A
    Vasc Health Risk Manag; 2014; 10():319-26. PubMed ID: 24920915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Managing Diabetes During Ramadan Conversation Map intervention: A difference-in-differences (self-comparison) design.
    Srulovici E; Leventer-Roberts M; Curtis B; He X; Hoshen M; Rotem M; Bachrach A; Reges O; Key C; Levin-Iaina N; Strizek A; Feldman B
    Int J Nurs Stud; 2019 Jul; 95():65-72. PubMed ID: 31121385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.